CN1399542A - 药用载体制剂 - Google Patents

药用载体制剂 Download PDF

Info

Publication number
CN1399542A
CN1399542A CN00816307A CN00816307A CN1399542A CN 1399542 A CN1399542 A CN 1399542A CN 00816307 A CN00816307 A CN 00816307A CN 00816307 A CN00816307 A CN 00816307A CN 1399542 A CN1399542 A CN 1399542A
Authority
CN
China
Prior art keywords
compositions
approximately
mixture
pharmaceutical composition
polysorbate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN00816307A
Other languages
English (en)
Chinese (zh)
Inventor
J·K·尤恩
R·W·桑德斯
M·B·法齐
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of CN1399542A publication Critical patent/CN1399542A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CN00816307A 1999-09-27 2000-09-26 药用载体制剂 Pending CN1399542A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40616499A 1999-09-27 1999-09-27
US09/406,164 1999-09-27

Publications (1)

Publication Number Publication Date
CN1399542A true CN1399542A (zh) 2003-02-26

Family

ID=23606801

Family Applications (1)

Application Number Title Priority Date Filing Date
CN00816307A Pending CN1399542A (zh) 1999-09-27 2000-09-26 药用载体制剂

Country Status (18)

Country Link
EP (1) EP1216029A1 (cs)
JP (1) JP2003510267A (cs)
KR (1) KR20020064289A (cs)
CN (1) CN1399542A (cs)
AR (1) AR025867A1 (cs)
AU (1) AU7716100A (cs)
BR (1) BR0014308A (cs)
CA (1) CA2388471A1 (cs)
CZ (1) CZ20021082A3 (cs)
EA (1) EA200200415A1 (cs)
HK (1) HK1044485A1 (cs)
HU (1) HUP0202652A3 (cs)
IL (1) IL148543A0 (cs)
MX (1) MXPA02003190A (cs)
NO (1) NO20021476L (cs)
PL (1) PL354331A1 (cs)
WO (1) WO2001022942A1 (cs)
ZA (1) ZA200203311B (cs)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100342856C (zh) * 2003-04-10 2007-10-17 上海医药工业研究院 达那唑半固体骨架制剂的组合物
CN101360485B (zh) * 2005-10-26 2013-04-17 班纳制药公司 作为胶囊填充物的基于亲水性载体的双重控释基质系统
CN111032004A (zh) * 2017-12-20 2020-04-17 弗门尼舍有限公司 口腔护理组合物

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7138393B2 (en) 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
US20030105144A1 (en) * 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
WO2004073692A1 (ja) * 2003-02-18 2004-09-02 Yamashita, Shinji 難水溶性薬物のハードカプセル剤
CN101351196B (zh) 2005-10-26 2013-07-03 班纳制药公司 作为胶囊填充物的基于亲脂性载体的双重控释基质系统
WO2008055148A2 (en) * 2006-10-31 2008-05-08 Wyeth Semi-solid formulations of phospholipase enzyme inhibitors
EP3733826B1 (en) * 2019-05-03 2024-07-17 The Procter & Gamble Company Particle treatment compositions comprising an antioxidant
AU2023292098A1 (en) * 2022-06-13 2025-01-16 R.P. Scherer Technologies, Llc Enteric bisacodyl softgel capsule

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3636123A1 (de) * 1986-10-23 1988-05-05 Rentschler Arzneimittel Arzneizubereitungen zur oralen verabreichung, die als einzeldosis 10 bis 240 mg dihydropyridin enthalten
WO1995022331A1 (en) * 1994-02-18 1995-08-24 Cephalon, Inc. Aqueous indolocarbazole solutions
US6287594B1 (en) * 1998-01-20 2001-09-11 Edward S. Wilson Oral liquid compositions

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100342856C (zh) * 2003-04-10 2007-10-17 上海医药工业研究院 达那唑半固体骨架制剂的组合物
CN101360485B (zh) * 2005-10-26 2013-04-17 班纳制药公司 作为胶囊填充物的基于亲水性载体的双重控释基质系统
CN111032004A (zh) * 2017-12-20 2020-04-17 弗门尼舍有限公司 口腔护理组合物
CN111032004B (zh) * 2017-12-20 2023-10-20 弗门尼舍有限公司 口腔护理组合物
US11938209B2 (en) 2017-12-20 2024-03-26 Firmenich Sa Oral care compositions

Also Published As

Publication number Publication date
PL354331A1 (en) 2004-01-12
EA200200415A1 (ru) 2002-10-31
NO20021476L (no) 2002-04-16
BR0014308A (pt) 2002-05-21
WO2001022942A1 (en) 2001-04-05
AU7716100A (en) 2001-04-30
HUP0202652A2 (hu) 2004-05-28
IL148543A0 (en) 2002-09-12
HK1044485A1 (zh) 2002-10-25
CA2388471A1 (en) 2001-04-05
AR025867A1 (es) 2002-12-18
ZA200203311B (en) 2003-12-31
MXPA02003190A (es) 2002-09-30
JP2003510267A (ja) 2003-03-18
EP1216029A1 (en) 2002-06-26
KR20020064289A (ko) 2002-08-07
HUP0202652A3 (en) 2004-06-28
CZ20021082A3 (cs) 2002-06-12
NO20021476D0 (no) 2002-03-25

Similar Documents

Publication Publication Date Title
US6437006B1 (en) Pharmaceutical carrier formulation
CN1767856A (zh) 用作c型肝炎病毒蛋白酶抑制剂的药物组合物
CN1170539C (zh) 含有伊曲康唑的抗真菌口服组合物及其制备方法
CN1273130C (zh) 具有增大的生物利用率的口服活性紫杉烷衍生物的药物组合物
CN1090509A (zh) 药用组合物
KR20040089605A (ko) Ｃ형 간염 바이러스 프로테아제 억제제에 대한 약제학적조성물
CN1124457A (zh) 含有醇和疏水性药物的改良药用组合物
CN1547467A (zh) 包含伊曲康唑的组合物和它们的制备方法
CN1079907A (zh) 药物组合物
CN1422149A (zh) 药物组合物
CN1097597A (zh) 环孢菌素软胶囊组合物
CN1856321A (zh) 降钙素在骨关节炎中的用途
CN1543359A (zh) 可生物利用的口服剂型醋氯芬酸组合物及其制备方法
CN1494920A (zh) 含有环孢菌素的软胶囊制剂
CN1602206A (zh) 含有氮杂环丁烷衍生物的药物组合物
MXPA02003190A (es) Formulacion para portadores farmaceuticos.
CN1468097A (zh) 包含莫达非尼化合物的组合物
CN1240379C (zh) 过氧化脂质降低剂组合物
US6352718B1 (en) Vasopressin antagonist formulation and process
CN1080113C (zh) 1,2,4－苯并三嗪氧化物的口服凝胶胶囊配方
CN1717219A (zh) 用于联苯二甲双酯口服给药的微乳组合物
CN1539429A (zh) 3’-脱氧腺苷在制备降血脂药物中的应用
CN1729998A (zh) 一种治疗癌症的华蟾素制剂
CN1430965A (zh) 一种葛根素软胶囊及其制备方法
CN1391466A (zh) 血管升压素拮抗剂制剂和方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication